CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-12 | Kennedy Brendan President and CEO | Grant or award · Class 1 Common Stock | +158,746 | 158,746 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award | +476,641 | 476,641 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award | +833,351 | 833,351 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award | +2,130,577 | 2,130,577 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award · Stock Option (Right to Buy) | +21,458 | 21,458 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award · Stock Option (Right to Buy) | +107,290 | 107,290 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award · Stock Option (Right to Buy) | +107,290 | 107,290 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award · Stock Option (Right to Buy) | +21,458 | 21,458 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award · Stock Option (Right to Buy) | +107,290 | 107,290 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award · Stock Option (Right to Buy) | +21,458 | 21,458 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award · Stock Option (Right to Buy) | +107,290 | 107,290 | ||
| 2019-12-12 | Auerbach Michael Director | Grant or award · Stock Option (Right to Buy) | +107,290 | 107,290 | ||
| 2019-12-11 | Kennedy Brendan President and CEO | Sale | −100,000 | $18.30 | $1.8M | 153,303 |
| 2019-12-02 | Auerbach Michael Director | Option exercise | +18,750 | $7.76 | $146K | 31,875 |
| 2019-12-02 | Auerbach Michael Director | Sale | −31,875 | $19.05 | $607K | 0 |
| 2019-12-02 | Auerbach Michael Director | Sale | −7,537 | $19.05 | $144K | 42,928 |
| 2019-12-02 | Auerbach Michael Director | Sale | −900 | $19.81 | $18K | 42,028 |
| 2019-12-02 | Auerbach Michael Director | Option exercise · Stock Option (Right to Buy) | −18,750 | 31,250 | ||
| 2019-12-01 | St.Clare Christine Director | Option exercise | +2,188 | 9,125 | ||
| 2019-12-01 | St.Clare Christine Director | Option exercise · Restricted Stock Units | −2,188 | 21,875 |
Page 44 of 49 · 968 trades